OPTH logo

Optimi Health Corp.

OPTH
Healthcare|Drug Manufacturers - Specialty & Generic|CA
$2.34
-0.05 (-2.09%)
Tangible Book / Share
$4.10
Cash / Share
$3.04

About

Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.

Stock Price

-70.0%(1Y)
1M
-42.8%
3M
-53.7%
6M
-68.5%
YTD
-65.8%
1Y
-67.6%
3Y
-37.6%
5Y
-84.3%

Pipeline Summary

1 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Withdrawn: 1

Key Facts

Market Cap$13.4M
Employees6
CEODane Stevens
IPO DateMay 20, 2026
Beta1.48
52-Week Range$1.9 – $8.84
Avg Volume42,960
ExchangeNASDAQ
Websiteoptimi.net

Ownership

Float81.0%
Shares Outstanding5.7M

Peers

MOOD.CNDoseology Sciences Inc.
$801.2K
PSYC.CNPsyched Wellness Ltd.
$2.0M
Data last updated: Nov 9, 2026, 04:26 AM